Literature DB >> 10619655

Peripheral binding site is involved in the neurotrophic activity of acetylcholinesterase.

F J Muñoz1, R Aldunate, N C Inestrosa.   

Abstract

Acetylcholinesterase (AChE) catalyses the hydrolysis of the neurotransmitter acetylcholine and it has been implicated in several non-cholinergic actions, including neurite outgrowth and amyloid formation. We have studied the trophic function of brain AChE on neuronal cell metabolism and proliferation as well as the enzyme domain involved in such effects. Low AChE concentrations (0.1-2.5 nM) stimulated neurite outgrowth and induced cell proliferation as measured by MTT reduction and [3H]thymidine incorporation. The action of AChE was not affected by edrophonium and tacrine both active site inhibitors, but it was abolished by propidium and gallamine, two peripheral anionic binding site (PAS) ligands. We conclude that the PAS domain of AChE is involved in the neurotrophic activity of the enzyme.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10619655     DOI: 10.1097/00001756-199911260-00029

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  11 in total

1.  Molecular docking study on the "back door" hypothesis for product clearance in acetylcholinesterase.

Authors:  Laleh Alisaraie; Gregor Fels
Journal:  J Mol Model       Date:  2005-12-09       Impact factor: 1.810

2.  Astrocytes protect against diazinon- and diazoxon-induced inhibition of neurite outgrowth by regulating neuronal glutathione.

Authors:  Daniella M Pizzurro; Khoi Dao; Lucio G Costa
Journal:  Toxicology       Date:  2014-02-19       Impact factor: 4.221

Review 3.  Readthrough acetylcholinesterase: a multifaceted inducer of stress reactions.

Authors:  Gabriel Zimmerman; Hermona Soreq
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

4.  Excessive expression of acetylcholinesterase impairs glutamatergic synaptogenesis in hippocampal neurons.

Authors:  Haiheng Dong; Yun-Yan Xiang; Noa Farchi; William Ju; Yaojiong Wu; Liwen Chen; Yutian Wang; Binyamin Hochner; Burton Yang; Hermona Soreq; Wei-Yang Lu
Journal:  J Neurosci       Date:  2004-10-13       Impact factor: 6.167

5.  Chlorpyrifos and chlorpyrifos-oxon inhibit axonal growth by interfering with the morphogenic activity of acetylcholinesterase.

Authors:  Dongren Yang; Angela Howard; Donald Bruun; Mispa Ajua-Alemanj; Cecile Pickart; Pamela J Lein
Journal:  Toxicol Appl Pharmacol       Date:  2007-11-17       Impact factor: 4.219

6.  Differential effects of two hexahydropyrroloindole carbamate-based anticholinesterase drugs on the amyloid beta protein pathway involved in Alzheimer's disease.

Authors:  Debomoy K Lahiri; George M Alley; David Tweedie; Demao Chen; Nigel H Greig
Journal:  Neuromolecular Med       Date:  2007       Impact factor: 3.843

7.  A wrench in the works of human acetylcholinesterase: soman induced conformational changes revealed by molecular dynamics simulations.

Authors:  Brian J Bennion; Sebnem G Essiz; Edmond Y Lau; Jean-Luc Fattebert; Aiyana Emigh; Felice C Lightstone
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

8.  Acetylcholinesterase readthrough peptide shares sequence similarity to the 28-53 peptide sequence of the acetylcholinesterase adhesion-mediating site and competes for ligand binding in vitro.

Authors:  Glynis Johnson; Samuel W Moore
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 2.866

9.  Virtual screening and biological evaluation of piperazine derivatives as human acetylcholinesterase inhibitors.

Authors:  Kavitha Raj Varadaraju; Jajur Ramanna Kumar; Lingappa Mallesha; Archana Muruli; Kikkeri Narasimha Shetty Mohana; Chethan Kumar Mukunda; Umesha Sharanaiah
Journal:  Int J Alzheimers Dis       Date:  2013-10-28

10.  Development of a CNS-permeable reactivator for nerve agent exposure: an iterative, multi-disciplinary approach.

Authors:  Brian J Bennion; Michael A Malfatti; Nicholas A Be; Heather A Enright; Saphon Hok; C Linn Cadieux; Timothy S Carpenter; Victoria Lao; Edward A Kuhn; M Windy McNerney; Felice C Lightstone; Tuan H Nguyen; Carlos A Valdez
Journal:  Sci Rep       Date:  2021-07-30       Impact factor: 4.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.